Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.
To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.
Please help improve GET-Evidence by evaluating evidence for this variant!
Nonsense or frameshift alleles of this gene are associated with the autosomal dominant disease Kabuki syndrome. As PGP89 is not affected, this is likely a sequencing error.
Insufficiently evaluated not reviewed
(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)
Summary of published research, and additional commentary
Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI,
Beck AE, Tabor HK, Cooper GM, Mefford HC, Lee C, Turner EH, Smith JD, Rieder MJ,
Yoshiura K, Matsumoto N, Ohta T, Niikawa N, Nickerson DA, Bamshad MJ, Shendure J.
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat
Genet. 2010 Sep;42(9):790-3. doi: 10.1038/ng.646. Epub 2010 Aug 15. PubMed PMID:
20711175; PubMed Central PMCID: PMC2930028.
Exome sequencing identifies nonsense or frameshift alleles in MLL2 associated with the autosomal dominant disease Kabuki syndrome. The majority of the cases identified carry de novo alleles (12/14).
hu011C57 - CGI sample GS01669-DNA_B05 from PGP sample 86486261
het CTCACACCTCA @ chr12:49440517
PGP89 is scored as heterozygous for MLL2-V1432Shift but does not show symptoms of Kabuki syndrome. Frameshift alleles with lesions downstream of V1432 show the dominant phenotype (PMID: 20711175), so it is likely that this is a sequencing error.